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Abstract
Objectives: Epithelial barrier function is impaired in CF airways as an indirect
consequence of F508del-CFTR trafficking defect. The role of apico-basal polarity
is crucial in the process but little is known about the influence of Planar Cell
Polarity (PCP) which coordinates alignment of cell polarity across the tissue
plane. Methods: Expression of several PCP proteins including atypical cadherin
CELSR3 (Cadherin EGF LAG seven-pass G-type receptor 3) were quantified
in normal and CF primary human bronchial epithelial (HBE) cells and HBE
cell lines. To characterize the role of CELSR3 in epithelial polarity, CELSR3,
epithelial and mesenchymal markers expression were quantified after inducing
epithelial– mesenchymal transition (EMT) in HBEs monolayers with TGFb or
cisplatin. To determine if CELSR3, suspected to undergo homophilic interactions
to establish cell–cell interactions, is a key determinant of epithelial barrier function,
transepithelial electric resistance (TEER) was measu...
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32 Mediation of pro/anti-inﬂammatory balance by vardenaﬁl in
mouse CF macrophages is dependent on CFTR expression
B. Dhooghe1, S. Noel1, F. Huaux1, N. Panin1, T. Leal1. 1Universite´ Catholique
de Louvain, IREC − LTAP, Brussels, Belgium
Objectives: Having recently demonstrated that vardenaﬁl, a phosphodiesterase type
5 inhibitor, reduces LPS-induced inﬂammatory responses in CF mice, we hypoth-
esized that CF macrophages are characterized by a pro-inﬂammatory phenotype
which can be modulated by vardenaﬁl. We also want to study the role of CFTR in
this vardenaﬁl-induced immunomodulation of macrophages.
Methods: Macrophages were puriﬁed from lung homogenates from homozygous
F508del-CFTR, CFTR−/− (KO) and wild-type (WT) mice. To test the hypothesis
that macrophages activity is altered in F508del-CF and KO mice, macrophages dif-
ferentiation in pro-inﬂammatory (M1) effectors was studied after polarization with
LPS and IFN-g. Pro-inﬂammatory mediators TNF-a and NOS-2 were quantiﬁed by
ELISA or by quantitative RT-PCR.
Results: F508del-CF lung macrophages displayed an exaggerated pro-inﬂammatory
response to M1 mediators. Both TNF-a and NOS-2 levels were more than doubled.
Similar observations were made in macrophages isolated from KO mice, conﬁrming
that loss of CFTR promotes pro-inﬂammatory phenotype in macrophages. In
F508del-CF mice, vardenaﬁl reduced the expression of pro-inﬂammatory mediators
by at least 50%. However, vardenaﬁl failed to normalize TNF-a and NOS-2
expression in KO macrophages, suggesting that the presence of CFTR protein is
required for immunomodulation by vardenaﬁl.
Conclusion: Taken together, our results indicate that macrophages display a pro-
inﬂammatory proﬁle and play a critical role in inﬂammatory responses in CF. More-
over, the immunomodulatory effect of vardenaﬁl, which could thus be beneﬁcial in
CF pharmacotherapy, requires CFTR expression.
33 Procalcitonin and C reactive protein levels in hospitalised patients
receiving intravenous antibiotics
G. Fitch1, C. Etherington1, P. Whitaker1, M. Bosomworth2, D. Peckham1. 1Leeds
Teaching Hospitals NHS Trust, Leeds Adult Cystic Fibrosis Unit, Leeds, United
Kingdom; 2Leeds Teaching Hospitals NHS Trust, Blood Sciences and Specialist
Laboratory Medicine, Leeds, United Kingdom
Objectives: Procalcitonin (PCT), a precursor of calcitonin is selectively raised in
bacterial infections. The aim of this pilot study was to investigate the role of PCT
as a surrogate marker of infection in adults with CF and to discriminate between
infection and inﬂammation in patients with elevated C reactive protein (CRP).
Methods: Adults with CF receiving hospital intravenous antibiotics for a pulmonary
exacerbation were recruited. PCT levels were prospectively measured in patients
with elevated C reactive protein (CRP).
Results: To date 11 subjects, median (range) age, 32 (21−51) yrs have been
investigated. CRP and Procalcitonin levels were 185 (69–283) mg/L and 0.3 (<0.01–
49.8) ug/L respectively. In ﬁve cases, PCT levels were 0.2 ug/L despite signiﬁcant
elevation in CRP. In two cases PCT levels were 0.1 ug/L and a clinical diagnosis
of viral illness or a Tazocin reaction were suspected. In both cases full resolution
occurred after discontinuing antibiotics. The highest PCT levels occurred in a
patient with a CRP of 381mg/L and following severe Inﬂuenza A H3 (seasonal)
infection.
Conclusion: PCT is a more speciﬁc marker of severe infection than conventional
markers such as CRP. Preliminary data suggests that PCT may be useful in
discriminating between severe pulmonary and endobronchial infection as well as
noninfectious inﬂammation. This study is ongoing.
34 Phagocyte collaboration for the control of Pseudomonas
aeruginosa
S. Muntaka1, A. Asante1, M. Ca´mara2, L. Martı´nez-Pomares2. 1The University
of Nottingham, Immunology, Nottingham, United Kingdom; 2The University of
Nottingham, Nottingham, United Kingdom
Pseudomonas aeruginosa (PA) is an opportunistic pathogen that causes infections
in patients with compromised immunity. Several previous studies are animal based,
but we have established a human neutrophil/macrophage PA infection model to
investigate phagocyte collaboration in PA control.
Objectives:
i. to investigate the ability of human macrophage-neutrophil co-cultures to control
Pseudomonas growth, promote inﬂammation and cause tissue damage, and
ii. to determine how the presence of pro-inﬂammatory cytokines such as IFN-g
and IL-17A affect the outcome of the infection of macrophage-neutrophils co-
cultures with PA.
Methods: A robust procedure has been established where, neutrophils or
macrophages or both are infected with PA with or without cytokines under opsonic
and or non-opsonic conditions, and the samples analysed for bacterial colony
forming units (CFU) or Flow cytometry.
Results: The ﬁndings so far indicate:
1. macrophages have a minor effect on the control of PA but coordinate the immune
response to PA infection;
2. phagocytosis of PA by neutrophils under non-opsonic conditions depends on cell
density;
3. as expected, serum enhances neutrophil-mediated killing of PA;
4. IL-17A enhances neutrophil-mediated killing of PA under opsonic conditions
and
5. neutrophils synergise with macrophages in clearing PA infection.
Conclusions:
1. Macrophages coordinate the immune response to PA by producing a number of
cytokines.
2. Neutrophil control of PA infection is enhanced by human complement.
3. The cytokine IL-17A enhances the ability of human neutrophils to control PA
infection.
4. Neutrophils and macrophages collaborate in clearing PA infections.
35 Deﬁciency of the Planar Cell Polarity protein CELSR3 in CF
bronchial epithelial cells increases susceptibility to epithelial–
mesenchymal transition
S. Noel1, B. Dhooghe1, A. Dykmans1, W. Delbart1, T. Leal1. 1Universite´
Catholique de Louvain, Louvain Centre for Toxicology and Applied Pharmacology,
Brussels, Belgium
Objectives: Epithelial barrier function is impaired in CF airways as an indirect
consequence of F508del-CFTR trafﬁcking defect. The role of apico-basal polarity
is crucial in the process but little is known about the inﬂuence of Planar Cell
Polarity (PCP) which coordinates alignment of cell polarity across the tissue plane.
Methods: Expression of several PCP proteins including atypical cadherin CELSR3
(Cadherin EGF LAG seven-pass G-type receptor 3) were quantiﬁed in normal
and CF primary human bronchial epithelial (HBE) cells and HBE cell lines.
To characterize the role of CELSR3 in epithelial polarity, CELSR3, epithelial
and mesenchymal markers expression were quantiﬁed after inducing epithelial–
mesenchymal transition (EMT) in HBEs monolayers with TGFb or cisplatin. To
determine if CELSR3, suspected to undergo homophilic interactions to establish
cell–cell interactions, is a key determinant of epithelial barrier function, transep-
ithelial electric resistance (TEER) was measured after silencing CELSR3 expression
in 16HBEs.
Results: HBEs expressed several PCP proteins, including CELSR3 for which
expression was downregulated in CF-HBEs compared to non-CF cells. Both TGFb
and cisplatin induced concomitant loss of CELSR3 and epithelial marker ZO-1 and
gain of mesenchymal (i.e. proﬁbrotic) markers vimentin and ﬁbronectin. CELSR3
siRNA in 16HBE cells enhanced TGFb-induced EMT. However, CELSR3 siRNA
did not modulate TEER, indicating that CELSR3 is an epithelial marker but not a
direct determinant of intercellular junction tightness.
Conclusion: CELSR3 is an epithelial marker down-regulated in CF-HBEs. Loss of
CELSR3 function may confer a proﬁbrotic phenotype to CF-HBEs cells.
